Cargando…

Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder, which is associated with memory deficit and global cognitive decline. Age is the greatest risk factor for AD and, in recent years, it is becoming increasingly appreciated that aging-related neuroinflammation plays a key role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernando, Kurukulasooriya Kavindya Madushani, Wijayasinghe, Yasanandana Supunsiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492950/ https://www.ncbi.nlm.nih.gov/pubmed/34630044 http://dx.doi.org/10.3389/fncel.2021.746631

Ejemplares similares

Comparison of four low-cost carbapenemase detection tests and a proposal of an algorithm for early detection of carbapenemase-producing Enterobacteriaceae in resource-limited settings
por: Kumudunie, Wirittamulla Gamage Maheshika, et al.
Publicado: (2021)

The role of sirtuins in Alzheimer's disease
por: Lalla, Rakhee, et al.
Publicado: (2013)

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
por: Yang, Qianjie, et al.
Publicado: (2020)

Sirtuins promote brain homeostasis, preventing Alzheimer’s disease through targeting neuroinflammation
por: Watroba, Mateusz, et al.
Publicado: (2022)

Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?
por: Cerovic, Milica, et al.
Publicado: (2019)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
por: Saha, Sarmistha, et al.
Publicado: (2022)

Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds
por: Ilyas, Ashal, et al.
Publicado: (2022)

Producing Proficient Methyl Donors from Alternative Substrates of S-Adenosylmethionine Synthetase
por: Wijayasinghe, Yasanandana S., et al.
Publicado: (2014)

Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
por: Yan, Jiayi, et al.
Publicado: (2022)

Brain injury, neuroinflammation and Alzheimer's disease
por: Breunig, Joshua J., et al.
Publicado: (2013)

Sirtuins in neurodegenerative diseases: an update on potential mechanisms
por: Min, Sang-Won, et al.
Publicado: (2013)

Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
por: Morales, Inelia, et al.
Publicado: (2014)

Neuroinflammation and Brain Functional Disconnection in Alzheimer’s Disease
por: Baglio, Francesca, et al.
Publicado: (2013)

Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
por: Marttinen, Mikael, et al.
Publicado: (2018)

Porphyromonas gingivalis-Induced Neuroinflammation in Alzheimer’s Disease
por: Olsen, Ingar
Publicado: (2021)

Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
por: Sung, Pi-Shan, et al.
Publicado: (2020)

Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases
por: Han, Seol-Heui
Publicado: (2009)

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
por: Weng, Shiting, et al.
Publicado: (2022)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2016)

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)

Phenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation
por: Hornedo-Ortega, Ruth, et al.
Publicado: (2018)

In vitro anti-diabetic effects and phytochemical profiling of novel varieties of Cinnamomum zeylanicum (L.) extracts
por: Wariyapperuma, W.A. Niroshani M., et al.
Publicado: (2020)

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease
por: De Felice, Fernanda G., et al.
Publicado: (2015)

The Influence of Nutrition in Alzheimer's Disease: Neuroinflammation and the Microbiome vs. Transmissible Prion
por: Bello-Corral, Laura, et al.
Publicado: (2021)

The effects of resistance exercise on cognitive function, amyloidogenesis, and neuroinflammation in Alzheimer’s disease
por: Azevedo, Caroline Vieira, et al.
Publicado: (2023)

The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer’s Disease and Spinal Cord Injury
por: Gong, Bing, et al.
Publicado: (2016)

Network pharmacology identify intersection genes of quercetin and Alzheimer’s disease as potential therapeutic targets
por: Wei, Caihui, et al.
Publicado: (2022)

Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
por: Das, Bhaskar C., et al.
Publicado: (2019)

Sirtuins in Neuroendocrine Regulation and Neurological Diseases
por: Fujita, Yuki, et al.
Publicado: (2018)

Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease
por: Dourado, Naiara Silva, et al.
Publicado: (2020)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
por: Wang, Qinqin, et al.
Publicado: (2015)

Targeting Neuroinflammation to Treat Alzheimer’s Disease
por: Ardura-Fabregat, A., et al.
Publicado: (2017)

Sirtuins as Potential Therapeutic Targets for Hepatitis B Virus Infection
por: Kong, Fanyun, et al.
Publicado: (2021)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Alzheimer’s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target
por: Zhang, Meng, et al.
Publicado: (2021)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
por: Traikapi, Artemis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a24k60u62vern2kq0u1tpdc7ol